Publications

Pini, L., Jacquemot, C., Cagnin, A., Meneghello, F., Semenza, C., Mantini, D. & Vallesi, A. (2020). Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review. Human Brain Mapping, 1(14), 256-269. doi:10.1002/hbm.24790

Whone, A., Bailey, D., Remy, P., Pavese, N. & Brooks, D. (2004). A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45(7), 1135-45.

Lahoud , N., Abbas , M., Salameh , P., Saleh, N., Abes, S., Hosseini, H. & Gebeily S, S. (2017). A retrospective analysis of 254 acute stroke cases admitted to two university hospitals in Beirut: classification and associated factors. Funct Neurol, 32(1), 41-48

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & Cyst-Hd Study, G. (2017). A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 32(6), 932-936. doi:10.1002/mds.27010

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & CYST-HD Study Group, . (2017). A randomized, Double-Blind, placebo-controlled trial evaluating cystéamine in Huntington’s disease. Mov. Disord., 32(6), 932-936

Lunven, M., Hernandez Dominguez, K., Youssov, K., Hamet Bagnou, J., Fliss, R. , Vandendriessche, H., Bapst, B. , Morgado, G., Remy, P., Schubert, R. , Reilmann, R., Busse, M., Craufurd, D., Massart, R., Rosser, A. & Bachoud-Levi, A. (2023). A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington's disease. Brain communications, 5(2), fcad043. doi:10.1093/braincomms/fcad043

Ribeiro, M., Thobois, S., Lohmann, E., Du Montcel, S., Lesage, S., Pelissolo, A., Dubois, B., Mallet, L., Pollak, P., Agid, Y., Broussolle, E., Brice, A., Remy, P. & French Parkinson'S Disease Genetics Study, G. (2009). A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 50(8), 1244-50. doi:10.2967/jnumed.109.063529

Dhaenens, C., Burnouf, S., Simonin, C., Van Brussel, E., Duhamel, A., Defebvre, L., Duru, C., Vuillaume, I., Cazeneuve, C., Charles, P., Maison, P., Debruxelles, S., Verny, C., Gervais, H., Azulay, J., Tranchant, C., Bachoud-Levi, A., Durr, A., Buée, L., Krystkowiak, P., Sablonnière, B., Blum, D. & Huntington French Speaking, N. (2009). A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiology of disease, 35(3), 474-6. doi:10.1016/j.nbd.2009.06.009

Teichmann, M., Rosso, C., Martini, J., Bloch, I., Brugières, P., Duffau, H., Lehericy, S. & Bachoud-Levi, A. (2015). A cortical-subcortical syntax pathway linking Broca's area and the striatum. Human brain mapping, 36(6), 2270-83. doi:10.1002/hbm.22769

Jacquemot, C. & Bachoud-Levi, A. (2021). A case-study of language-specific executive disorder. Cognitive Neuropsychology, 38(2). doi:10.1080/02643294.2021.1941828

Ribeiro, M., Idbaih, A., Thomas, C., Remy, P., Martin-Duverneuil, N., Samson, Y., Donadieu, J. & Hoang-Xuan, K. (2008). 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease. Journal of neurology, 255(4), 575-80. doi:10.1007/s00415-008-0751-8

Rieu, D., Bachoud-Levi, A., Laurent, A., Jurion, E. & Dalla Barba , G. (2006). [French adaptation of the Hopkins Verbal Learning Test] Revue neurologique. doi:10.1016/s0035-3787(06)75069-x